Literature DB >> 33522344

Evaluation of risk factors for and subsequent mortality from poor graft function (PGF) post allogeneic stem cell transplantation.

Ashvind Prabahran1,2,3, Rachel Koldej2,3, Lynette Chee1,2,3, Eric Wong1,2, David Ritchie1,2,3.   

Abstract

Poor Graft Function (PGF) is defined by multi-lineage cytopenias with complete donor chimerism post allogeneic transplantation, Risk factors for and subsequent mortality from PGF were assessed in our transplant cohort. Non-sibling donor [OR 1.97; 95% CI 1.02-3.70], ICU admission [OR 5.28; 95% CI 2.29-11.88] or blood culture positivity within the first 30 days [OR 1.67; 95% CI 1.07-2.62], grade III-IV acute graft vs host disease (GVHD) [OR 4.082; 95% CI 2.31-7.16] and CMV viremia [OR 2.43; 95% CI 1.53-3.88] and were significantly associated with development of PGF. PGF patients without count recovery had a 2 year OS of 6%. Severe GVHD, thrombocytopenia and anemia portended inferior survival and were used to develop a prognostic score for mortality from PGF. This analysis identifies risk factors predictive of PGF and poor survival in those without recovery.

Entities:  

Keywords:  Poor graft function; allogeneic stem cell transplantation; complications

Mesh:

Substances:

Year:  2021        PMID: 33522344     DOI: 10.1080/10428194.2021.1872072

Source DB:  PubMed          Journal:  Leuk Lymphoma        ISSN: 1026-8022


  4 in total

Review 1.  Non-relapse cytopenias following allogeneic stem cell transplantation, a case based review.

Authors:  Ashvind Prabahran; Rachel Koldej; Lynette Chee; Jeff Szer; David Ritchie
Journal:  Bone Marrow Transplant       Date:  2022-07-23       Impact factor: 5.174

Review 2.  Recent Advancements in Poor Graft Function Following Hematopoietic Stem Cell Transplantation.

Authors:  Yan Man; Zhixiang Lu; Xiangmei Yao; Yuemin Gong; Tonghua Yang; Yajie Wang
Journal:  Front Immunol       Date:  2022-06-02       Impact factor: 8.786

3.  The Incidence, Outcomes, and Risk Factors of Secondary Poor Graft Function in Haploidentical Hematopoietic Stem Cell Transplantation for Acquired Aplastic Anemia.

Authors:  Fan Lin; Tingting Han; Yuanyuan Zhang; Yifei Cheng; Zhengli Xu; Xiaodong Mo; Fengrong Wang; Chenhua Yan; Yuqian Sun; Jingzhi Wang; Feifei Tang; Wei Han; Yuhong Chen; Yu Wang; Xiaohui Zhang; Kaiyan Liu; Xiaojun Huang; Lanping Xu
Journal:  Front Immunol       Date:  2022-05-09       Impact factor: 8.786

Review 4.  Clinical features, pathophysiology, and therapy of poor graft function post-allogeneic stem cell transplantation.

Authors:  Ashvind Prabahran; Rachel Koldej; Lynette Chee; David Ritchie
Journal:  Blood Adv       Date:  2022-03-22
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.